A role for ATF2 in regulating MITF and melanoma development.
about
PKCĪµ promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondriaKATs in cancer: functions and therapiesPathways and therapeutic targets in melanomaA dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitorsFunctional specialization in proline biosynthesis of melanomaRhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damagePostnatal lineage mapping of follicular melanocytes with the Tyr::CreER(T) (2) transgenePerformance of a simple chromatin-rich segmentation algorithm in quantifying basal cell carcinoma from histology imagesInhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2MITF in melanoma: mechanisms behind its expression and activity.Bim and VDAC1 are hierarchically essential for mitochondrial ATF2 mediated cell deathActivation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect.ATF2 - at the crossroad of nuclear and cytosolic functions.MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons.Impact of copy number variations (CNVs) on long-range gene regulation at the HoxD locus.Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma.The role of mitogen- and stress-activated protein kinase pathways in melanoma.Modelling melanoma in mice.The three M's: melanoma, microphthalmia-associated transcription factor and microRNA.The roles of ATF2 (activating transcription factor 2) in tumorigenesis.Driving transcriptional regulators in melanoma metastasis.ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.SOX2 modulates levels of MITF in normal human melanocytes, and melanoma lines in vitroActivating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.ATF2 alters melanocyte response and macrophage recruitment in UV-irradiated neonatal mouse skinInhibitor of differentiation-4 (Id4) stimulates pigmentation in melanoma leading to histiocyte infiltration.Decreased melanoma proliferation and cell survival: turn down your SOX10.SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.Genetic variation in the MITF promoter affects skin colour and transcriptional activity in black-boned chickens.Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells.SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
P2860
Q24304390-9A4BAAC0-CEDD-4DE2-A4F3-4E566919B676Q26859355-A58804A8-39E2-4236-8EED-D69089F7C916Q26865736-BCFFB2D0-9D22-46EF-8791-ED90C7C85F13Q27321082-C631DB2F-B778-415D-900F-70DC065A2579Q28118829-49DF4335-4C57-4E20-B11A-2F52C67AAF55Q28274939-4FF1D0AD-0071-4532-90CE-3FFD5C0F827BQ33664891-927C54E2-09BB-4C54-9F7A-38B105A3FBE0Q34129708-D70C4423-0961-4A4B-9BDD-6657718BE495Q34433459-D341A8AE-B0DC-4820-B7F2-975A029680D0Q34669835-37A50882-2481-48DB-A7A8-8C8F97EECE9DQ35187734-D11D7B41-0885-44C2-81B0-C582D90C4E3EQ35293180-C56D3092-6661-44D4-864D-3631D4340ABBQ35571900-3CBB99B6-22B7-4F41-901F-96FD1C66DA70Q35605096-AAB1321C-FC5C-403C-99CC-CA78B1619DD5Q36211955-EB53675C-1A6B-47A2-A832-9981ACAF95A5Q36320144-F534BB4F-514C-45B4-A34A-3B5C60C03FC4Q36412675-A5EA978F-666B-4431-A1EC-A30080654DD7Q36483754-817F1BBA-D8A1-42F8-AA5C-EE6EC8F16E86Q36546659-42043616-14C3-47D6-BD1E-C44AF1E7B6FDQ36957604-D38FBA26-3A56-4FB0-B819-6ADA1583E88EQ37064522-3CA301A1-2326-448D-AA24-382666A9E41EQ37931402-EAE83077-E20F-41C0-BDA4-25FFCD74CCD9Q37943839-AAED4136-5592-4E19-B048-D3D1A9D81FC8Q37946457-BC5644DA-BEF4-43D9-A822-22C12112D8AFQ37977183-AF2A02BA-33A5-46B3-86BD-B45E85282DD5Q38017594-8152CC65-2D96-4AAA-AC9F-BD3C36E0EE39Q38943647-FA60DFF2-E383-4644-8E7E-AE7F6FA7127DQ39351432-1C39D452-37B5-4218-B06F-C5C137D167DFQ40002473-145835A5-3238-4573-B82D-6DD7C402BF23Q41285700-6ACAAF16-C460-44F4-9BA8-C4D38F3107C7Q42182349-F22AF6EA-A10C-44BD-963D-161D13500EEEQ43450163-755E14FA-A47F-409A-B562-94B3D870CAD2Q46718948-D6E30355-C748-48E0-A083-51C77A52CF44Q47690946-A2EBAC7B-CC90-4848-982F-0BA241095369Q52716813-EA21C46E-12C1-4517-B3AE-A5C8FDF3E92BQ55618243-9847BD86-C58E-46B6-A970-F64D34391BBE
P2860
A role for ATF2 in regulating MITF and melanoma development.
description
2010 nĆ® lÅ«n-bĆ»n
@nan
2010 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō“Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2010 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¤Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2010幓ć®č«ę
@ja
2010幓č«ę
@yue
2010幓č«ę
@zh-hant
2010幓č«ę
@zh-hk
2010幓č«ę
@zh-mo
2010幓č«ę
@zh-tw
2010幓č®ŗę
@wuu
name
A role for ATF2 in regulating MITF and melanoma development.
@ast
A role for ATF2 in regulating MITF and melanoma development.
@en
type
label
A role for ATF2 in regulating MITF and melanoma development.
@ast
A role for ATF2 in regulating MITF and melanoma development.
@en
prefLabel
A role for ATF2 in regulating MITF and melanoma development.
@ast
A role for ATF2 in regulating MITF and melanoma development.
@en
P2093
P2860
P50
P1433
P1476
A role for ATF2 in regulating MITF and melanoma development.
@en
P2093
Alexey Eroshkin
Anindita Bhoumik
Antimone Dewing
David M Kallenberg
Harriet Kluger
Hyeongnam Jeong
Jason Dehart
Marcus Bosenberg
Maryla Krajewska
P2860
P304
P356
10.1371/JOURNAL.PGEN.1001258
P577
2010-12-23T00:00:00Z